APOGEE THERAPEUTICS INC (APGE) Stock Analyst Ratings
USA - NASDAQ:APGE - US03770N1019 - Common Stock
53.32 USD
-0.5 (-0.93%)
53.32 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 90% to APGE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 95.54. This target is 79.18% above the current price.
APGE was analyzed by 16 analysts. The buy percentage consensus is at 90. So analysts seem to be very confident about APGE.
In the previous month the buy percentage consensus was at a similar level.
APGE was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-21 | Mizuho | Initiate | Outperform |
| 2025-10-09 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-25 | RBC Capital | Initiate | Outperform |
| 2025-08-28 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-02 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-13 | Citigroup | Initiate | Buy |
| 2025-02-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-11-27 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-25 | Canaccord Genuity | Initiate | Buy |
| 2024-10-25 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-10 | B of A Securities | Initiate | Buy |
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-05 | Guggenheim | Maintains | Buy -> Buy |
| 2024-03-05 | Stifel | Maintains | Buy -> Buy |
| 2024-01-03 | Guggenheim | Maintains | Buy -> Buy |
| 2023-12-20 | BTIG | Initiate | Buy |
| 2023-08-08 | TD Cowen | Initiate | Outperform |
| 2023-08-08 | Guggenheim | Initiate | Buy |
| 2023-08-08 | Stifel | Initiate | Buy |
| 2023-08-08 | Wedbush | Initiate | Outperform |
| 2023-08-08 | Jefferies | Initiate | Buy |
APOGEE THERAPEUTICS INC / APGE FAQ
What is the average price target for APOGEE THERAPEUTICS INC (APGE) stock?
16 analysts have analysed APGE and the average price target is 95.54 USD. This implies a price increase of 79.18% is expected in the next year compared to the current price of 53.32.
Can you provide the consensus rating for APOGEE THERAPEUTICS INC stock?
The consensus rating for APOGEE THERAPEUTICS INC (APGE) is 90 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for APGE stock?
The number of analysts covering APOGEE THERAPEUTICS INC (APGE) is 16.